Cannabis producer Tilray Brands (NASDAQ: TLRY) looked like a promising investment when it announced in 2020 that it was merging with then-rival Aphria. The reason I'm losing hope in Tilray is that it has been making aggressive moves that might jeopardize its overall operations. While the deal with Aphria was smart since the company was a low-cost producer, recent announcements involving MedMen and Hexo are less encouraging. Read More...
Reuters
Berkshire rejects shareholder call to replace Warren Buffett as chairman
Berkshire Hathaway Inc on Friday urged the rejection of four shareholder proposals recommending that it replace Warren Buffett as chairman, report on its plans to handle climate risk and reduce greenhouse gases, and improve diversity. The company, run by Buffett since 1965, also said the 91-year-old received $373,204 in compensation for 2021, down from $380,328 a year earlier, comprising his usual $100,000 salary plus personal and home security. Though Buffett’s salary is low for a chief executive officer of a major company, his 16.2% Berkshire stake comprises most of his $117.9 billion net worth, which Forbes magazine said makes him the world’s fifth-richest person.
Add Comment